Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial


Ghia, Paolo, Coutre, Steven E, Cheson, Bruce D, Barrientos, Jacqueline C, Hillmen, Peter, Pettitt, Andrew R ORCID: 0000-0002-0907-8950, Zelenetz, Andrew D, Shreay, Sanatan, Hallek, Michael and Furman, Richard R (2020) Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial. HAEMATOLOGICA, 105 (10). E519-E522. ISSN 0390-6078, 1592-8721

[thumbnail of GIL171005B_116 PRO letter_R1_draft 1_2019 11 08.docx] Text
GIL171005B_116 PRO letter_R1_draft 1_2019 11 08.docx - Author Accepted Manuscript
Download (365kB)
Item Type: Article
Uncontrolled Keywords: Humans, Purines, Antineoplastic Combined Chemotherapy Protocols, Quality of Life, Quinazolinones, Leukemia, Lymphocytic, Chronic, B-Cell
Depositing User: Symplectic Admin
Date Deposited: 10 Jun 2020 07:49
Last Modified: 06 Dec 2024 22:05
DOI: 10.3324/haematol.2019.238808
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3089893
Altmetric
Share
CORE (COnnecting REpositories)